Search

Shop

Donate

Your heartHealthy livingFor professionalsResearchHow you can helpAbout us

Practical guide to pharmacological lipid management

Heart Health Check Toolkit

/

Practical guide to pharmacological lipid management

Pharmacological guide and resources to help you manage patients with high cholesterol

High cholesterol is a significant risk factor of CVD and contributes to a third of coronary heart disease burden.1 Evidence suggests that statins are the most effective lipid lowering method and should be the first-line agent when managing patients with high cholesterol.2

In this pharmacological management guide, developed to help you manage patients with high cholesterol, you will find:

Cholesterol animation for patients

Use this short animation to help show your patients what high cholesterol is, and how it may increase their risk for heart disease.

More resources

Healthy lifestyle changes are also strongly recommended for management of cholesterol and other CVD risk factors. See Lifestyle management for more information.

Read next ...

Cholesterol and heart disease

Table of contents

  1. AIHW 2019a. Australian Burden of Disease Study 2015: Interactive data on disease burden, Cat. no. BOD 24. Canberra: AIHW.
  2. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. 2021. https://www.heartfoundation.org.au/conditions/fp-absolute-cvd-risk-clinical-guidelines
Group of three researchers or health professionals having a discussion
Toolkit contents

Explore the list of pages in the Heart Health Check Toolkit for health professionals.

Smiling general practitioner is speaking with another man across his desk
About the Toolkit

Supporting general practices to integrate Heart Health Checks into routine patient care, with a range of resources and easy-to-use tools in one place.

Female health professional smiling, wearing blue scrubs
Downloadable resources

A full list of ready-to-use resources available in this Toolkit

Last updated16 March 2024